CXCR4 as a Predictor of Response in Acute Myeloid Leukemia

被引:0
作者
Pastore, Domenico
Mestice, Anna
Giannoccaro, Margherita
Liso, Arcangelo
Martelli, Maria Paola
Carluccio, Paola
Albano, Francesco
Delia, Mario
Rossi, Antonella Russo
Leo, Manuela
Pannunzio, Alessandra
Liso, Vincenzo
Falini, Brunangelo
Specchia, Giorgina
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1011 / 1011
页数:1
相关论文
共 50 条
[21]   Use of polymeric CXCR4 inhibitors as siRNA delivery vehicles for the treatment of acute myeloid leukemia [J].
Wang, Yiqian ;
Xie, Ying ;
Williams, Jacob ;
Hang, Yu ;
Richter, Lisa ;
Becker, Michelle ;
Amador, Catalina ;
Oupicky, David ;
Hyde, R. Katherine .
CANCER GENE THERAPY, 2020, 27 (1-2) :45-55
[22]   Combining SDF-1/CXCR4 antagonism and chemotherapy in relapsed acute myeloid leukemia [J].
Fierro, F. A. ;
Brenner, S. ;
Oelschlaegel, U. ;
Jacobi, A. ;
Knoth, H. ;
Ehninger, G. ;
Illmer, T. ;
Bornhaeuser, M. .
LEUKEMIA, 2009, 23 (02) :393-396
[23]   Overexpression of CXCR4 Enhances the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia [J].
Biondi, Marta ;
Galimberti, Stefania ;
Cerina, Beatrice ;
Tomasoni, Chiara ;
Dotti, Gianpietro ;
Tettamanti, Sarah ;
Biondi, Andrea ;
Pievani, Alice ;
Serafini, Marta .
BLOOD, 2022, 140 :4500-4501
[24]   Use of polymeric CXCR4 inhibitors as siRNA delivery vehicles for the treatment of acute myeloid leukemia [J].
Yiqian Wang ;
Ying Xie ;
Jacob Williams ;
Yu Hang ;
Lisa Richter ;
Michelle Becker ;
Catalina Amador ;
David Oupický ;
R. Katherine Hyde .
Cancer Gene Therapy, 2020, 27 :45-55
[25]   CXCR4 Antagonists as Stem Cell Mobilizers and Therapy Sensitizers for Acute Myeloid Leukemia and Glioblastoma? [J].
Hira, Vashendriya V. V. ;
Van Noorden, Cornelis J. F. ;
Molenaar, Remco J. .
BIOLOGY-BASEL, 2020, 9 (02)
[26]   Combining SDF-1/CXCR4 antagonism and chemotherapy in relapsed acute myeloid leukemia [J].
F A Fierro ;
S Brenner ;
U Oelschlaegel ;
A Jacobi ;
H Knoth ;
G Ehninger ;
T Illmer ;
M Bornhäuser .
Leukemia, 2009, 23 :393-396
[27]   CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model [J].
Zhang, Y. ;
Patel, S. ;
Abdelouahab, H. ;
Wittner, M. ;
Willekens, C. ;
Shen, S. ;
Betems, A. ;
Joulin, V. ;
Opolon, P. ;
Bawa, O. ;
Pasquier, F. ;
Ito, M. ;
Fujii, N. ;
Gonin, P. ;
Solary, E. ;
Vainchenker, W. ;
Coppo, P. ;
De Botton, S. ;
Louache, F. .
CELL DEATH & DISEASE, 2012, 3 :e396-e396
[28]   CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model [J].
Y Zhang ;
S Patel ;
H Abdelouahab ;
M Wittner ;
C Willekens ;
S Shen ;
A Betems ;
V Joulin ;
P Opolon ;
O Bawa ;
F Pasquier ;
M Ito ;
N Fujii ;
P Gonin ;
E Solary ;
W Vainchenker ;
P Coppo ;
S De Botton ;
F Louache .
Cell Death & Disease, 2012, 3 :e396-e396
[29]   Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100 [J].
Nervi, Bruno ;
Ramirez, Pablo ;
Rettig, Michael P. ;
Uy, Geoffrey L. ;
Holt, Matthew S. ;
Ritchey, Julie K. ;
Prior, Julie L. ;
Piwnica-Worms, David ;
Bridger, Gary ;
Ley, Timothy J. ;
DiPersio, John F. .
BLOOD, 2009, 113 (24) :6206-6214
[30]   Targeting CXCR4/SDF-1 axis by lipopolymer complexes of siRNA in acute myeloid leukemia [J].
Landry, Breanne ;
Guel-Uludag, Hilal ;
Plianwong, Samarwadee ;
Kucharski, Cezary ;
Zak, Zoulika ;
Parmar, Manoj B. ;
Kutsch, Olaf ;
Jiang, Hongxing ;
Brandwein, Joseph ;
Uludag, Hasan .
JOURNAL OF CONTROLLED RELEASE, 2016, 224 :8-21